Literature DB >> 15947058

Altered motor nerve excitability in end-stage kidney disease.

Arun V Krishnan1, Richard K S Phoon, Bruce A Pussell, John A Charlesworth, Hugh Bostock, Matthew C Kiernan.   

Abstract

Although multiple toxins have been implicated in the development of uraemic neuropathy, no causative agent has been identified. In the present study, the excitability properties of lower limb motor nerves in patients with end-stage kidney disease treated with haemodialysis were measured before, during and after a standard 5 h haemodialysis session, in an attempt to explore the pathophysiology of uraemic neuropathy. Compound muscle action potentials were recorded from tibialis anterior and extensor digitorum brevis, following stimulation of the common peroneal nerve in 14 patients. Measures of excitability were assessed in relation to changes in serum levels of potential neurotoxins, including potassium, calcium, urea, uric acid, parathyroid hormone and beta-2-microglobulin. Before dialysis, measures of nerve excitability were significantly abnormal in the patient group for axons innervating tibialis anterior and extensor digitorum brevis, consistent with axonal depolarization: refractoriness was increased and superexcitability and depolarizing threshold electrotonus were reduced. Pre-dialysis excitability abnormalities were strongly correlated with serum K+. Correlation was also noted between the severity of symptoms and excitability abnormalities. Haemodialysis normalized the majority of nerve excitability parameters. In conclusion, lower limb motor axons in uraemic patients are depolarized before dialysis. The correlation between serum K+ and excitability measures indicates that hyperkalaemia is primarily responsible for uraemic depolarization, and a likely contributing factor to the development of neuropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947058     DOI: 10.1093/brain/awh558

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

Review 1.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

2.  A neurophysiological study of large- and small-diameter nerve fibers in the hands of hemodialysis patients.

Authors:  Miro Denislic; Merita Tiric-Campara; Halima Resić; Jasem Y Al-Hashel; Rok Zorec; Refet Gojak; Jan Ravnik
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

Review 3.  Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.

Authors:  Susanna B Park; Matthew C Kiernan; Steve Vucic
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Sensitivity to ischaemia of single sympathetic nerve fibres innervating the dorsum of the human foot.

Authors:  W J Z'Graggen; R Solà; N E Graf; J Serra; H Bostock
Journal:  J Physiol       Date:  2017-05-14       Impact factor: 5.182

Review 5.  Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

6.  Sensory nerve excitability and neuropathy in end stage kidney disease.

Authors:  A V Krishnan; R K S Phoon; B A Pussell; J A Charlesworth; M C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

7.  Axonal function in a family with episodic ataxia type 2 due to a novel mutation.

Authors:  Arun V Krishnan; Hugh Bostock; Jerome Ip; Michael Hayes; Shaun Watson; Matthew C Kiernan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

8.  Randomized, Controlled Trial of the Effect of Dietary Potassium Restriction on Nerve Function in CKD.

Authors:  Ria Arnold; Timothy J Pianta; Bruce A Pussell; Adrienne Kirby; Kate O'Brien; Karen Sullivan; Margaret Holyday; Christine Cormack; Matthew C Kiernan; Arun V Krishnan
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-11       Impact factor: 8.237

Review 9.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

10.  Frequency of Polyneuropathy in Patients on Long Term Peritoneal Dialysis Treatment.

Authors:  Taner Basturk; Yener Koc; Aarzu Ozdemir Kayalar; Figen Yilmaz; Nuri Baris Hasbal; Tamer Sakaci; Elbis Ahbap; Abdulkadir Unsal
Journal:  J Clin Diagn Res       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.